TraderByInstinct

240 bound, after dismal performance from $AMGN

NASDAQ:IBB   iShares Biotechnology ETF
0
$XBI selling continues as well

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.